C07C 247/00
Compounds containing azido groups
C07C247/00 (Compounds containing azido groups) appears on 595 US grants and 351 published applications in this corpus.
Search patents in C07C- Granted patents
- 595
- Published applications
- 351
- Assignees
- 358
- Inventors
- 1,314
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 10 | 0 |
| 1978 | 10 | 0 |
| 1979 | 2 | 0 |
| 1980 | 9 | 0 |
| 1981 | 12 | 0 |
| 1982 | 8 | 0 |
| 1983 | 9 | 0 |
| 1984 | 18 | 0 |
| 1985 | 12 | 0 |
| 1986 | 6 | 0 |
| 1987 | 6 | 0 |
| 1988 | 13 | 0 |
| 1989 | 9 | 0 |
| 1990 | 10 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 8 | 0 |
| 1994 | 15 | 0 |
| 1995 | 7 | 0 |
| 1996 | 26 | 0 |
| 1997 | 28 | 0 |
| 1998 | 15 | 0 |
| 1999 | 14 | 0 |
| 2000 | 15 | 0 |
| 2001 | 18 | 5 |
| 2002 | 11 | 8 |
| 2003 | 13 | 17 |
| 2004 | 9 | 9 |
| 2005 | 10 | 7 |
| 2006 | 7 | 13 |
| 2007 | 4 | 6 |
| 2008 | 4 | 7 |
| 2009 | 7 | 11 |
| 2010 | 5 | 20 |
| 2011 | 12 | 18 |
| 2012 | 11 | 16 |
| 2013 | 11 | 17 |
| 2014 | 15 | 19 |
| 2015 | 19 | 22 |
| 2016 | 21 | 19 |
| 2017 | 17 | 22 |
| 2018 | 17 | 10 |
| 2019 | 19 | 16 |
| 2020 | 18 | 13 |
| 2021 | 4 | 18 |
| 2022 | 10 | 11 |
| 2023 | 12 | 13 |
| 2024 | 8 | 16 |
| 2025 | 16 | 12 |
| 2026 | 6 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07C 247/02Compounds containing azido groups: with azido groups bound to acyclic carbon atoms301
- C07C 247/16Compounds containing azido groups: with azido groups bound to carbon atoms of93
- C07C 247/14Compounds containing azido groups: with azido groups bound to carbon atoms of59
- C07C 247/20Compounds containing azido groups: with azido groups acylated by carboxylic acids14
Recent patents
- Valiolamine derivatives as glucosidase inhibitors7 Jul 2026US 12,673,924 B2Emergent Product Development Gaithersburg Inc.
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Hydroxynorketamine analogues, compositions comprising same and methods of use thereof16 Jun 2026US 12,655,089 B2Spirify Pharma Inc.
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof24 Mar 2026US 12,583,967 B2Nof Corporation
- Methods of preparing N6-((2-azidoethoxy)carbonyl)lysine17 Mar 2026US 12,577,197 B2Sanofi
- Tertiary amine compounds containing an alkyne or an azide moiety and their use8 Oct 2026US 2026/0308116 A1Assistance Publique-Hopitaux de Paris
- Traceless reductively cleavable linker molecules for peptide purification6 Aug 2026US 2026/0226099 A1Gyros Protein Technologies AB
- Cannabinoid receptor 2 modulators16 Jul 2026US 2026/0200892 A1Hoffmann-La Roche Inc.
- Method for synthesis of diazabicyclo[6.2.0]decane related compounds14 May 2026US 2026/0132144 A1Eisai R&D Management Co., Ltd.
- Modulators of liver receptor homologue 1 (lrh-1) and uses26 Feb 2026US 2026/0055046 A1Emory University
Most cited
By later US patents
- Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents217US 5,688,819 AAllergan, Inc. · 1997
- Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents177US 6,403,649 B1Allergan Sales, Inc. · 2002
- Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity167US 5,919,970 AAllergan Sales, Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents111US 5,352,708 AAllergan, Inc. · 1994